Overview

Prophylactic Antibiotics in Measles

Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
Objective It is the objective to test whether the use of prophylactic antibiotics in measles infection will reduce the incidence of post-measles pneumonia and/or admissions to hospital with 50%. The possible impact on other complications of severe measles will also be measured.
Phase:
Phase 3
Details
Lead Sponsor:
Bandim Health Project
Collaborator:
Medical Research Council Unit, The Gambia
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination